Enovis CORP

Enovis Corporation (the Company , Enovis , we or us ) is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing, and distributing high-quality medical devices with a broad range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. Our products address the continuum of patient care from injury prevention to rehabilitation after surgery or injury or from degenerative disease, enabling people to regain or maintain their natural motion. We seek to leverage our Enovis Growth Excellence business system ( EGX ), a set of tools, processes, and culture, to continuously improve our ability to enable great patient outcomes and to drive and fuel growth. During the year ended December 31, 2025, we completed four acquisitions within our Reconstructive segment and three acquisitions within our Prevention & Recovery segment. These small acquisitions added complementary prevention & recovery product offerings, expanded distribution partners for the Company’s surgical implant products in Europe, and added a complementary surgical product technology. See Note 5 Acquisitions and Divestitures for further information. Our business management system, EGX, is integral to our operations. EGX is our culture and incorporates our values and drives our behaviors.